Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
ZS Zscaler Inc reports first quarter 2026 earnings per share ahead of analyst estimates notches small daily stock gain Is Boot Barn BOOT stock showing upward movement Investor Interest 20260418 Is LPL LPLA stock facing market pressure Q4 2025 Profit Exceeds Views PBF Energy Inc PBF Q4 2025 earnings far exceed analyst estimates shares gain 403 percent today What AdvanSix ASIX management is not saying enough about Pulls Back 20260506 The strategic moves Willdan Group WLDN is making now Drifts Lower 20260506 The organic vs inorganic growth story at DigiBrands DBGI News Analysis How a mother of Elon Musks children became a key witness in his lawsuit against Average Traders Outperform Wall Street on Prediction Markets NYT Reports Spencer Pratts Social Media Strategy Could Reshape Political Campaigning But Can It Win LA Mayoral Race Applied Digital APLD Price Target Raised by 3 at Needham IQVIA Holdings Assessing Factors Behind Its Investment Appeal Apples Record Rally Faces Crucial AI Test at WWDC Next Month Canadas Big Banks Expected to Report Solid Q2 Earnings but Outlook Takes Center Stage Amid Softening Economy LUNR Q1 2026 Earnings EPS Misses Expectations Amid PreRevenue Period Shares Surge 1572 UXIN Q1 2025 Earnings Loss Per Share Reported Amidst Market Challenges RITM Q1 2026 Earnings EPS Beats Estimates by 057 Stock Edges Higher Outset Medical Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher Sunrun RUN Q1 2026 Earnings Solar Leader Posts Record EPS Surprise Shares Rally Carscom Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher Precision Drilling PDS Drops 324 as Weakness Tests Support at 8524 Universe Pharmaceuticals Inc UPC Surges 9 as Momentum Builds Near Key Resistance Ballard Power Systems Surges 1155 as Hydrogen Momentum Builds BLDP Atkore Inc ATKR Surges 1125 Electrical Infrastructure Demand Fuels Rally Kazia Therapeutics KZIA Faces Sharp Decline as Biotech Volatility Resurfaces